D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 277,000
+55,000 (24.77%)
Oct 31, 2025, 1:40 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 2.41 trillion as of October 30, 2025. Its market cap has increased by 471.01% in one year.
Market Cap
2.41T
Enterprise Value
2.38T
Revenue
9.33B
Ranking
n/a
PE Ratio
n/a
Stock Price
277,000.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 2.41T, an increase of 534.97%. That is a compound annual growth rate of 244.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 2.41T | 369.25% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.90T |
| ALTEOGEN | 24.95T |
| SK Biopharmaceuticals | 8.97T |
| Yuhan | 8.77T |
| HLB Co., Ltd. | 6.30T |
| Peptron | 6.13T |
| PharmaResearch | 5.36T |